Literature DB >> 6408754

Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.

G Ostermann, U Till, K Thielmann.   

Abstract

"Saturated" and "unsaturated" platelet-activating factor (PAF) obtained from ratfish liver oil were proved to exert potent stimulation on human blood platelets. Using 0.025 to 1.0 mumol/1 PAF a dose-dependent platelet aggregation in platelet-rich plasma was observed. During PAF-induced irreversible aggregation a 9 to 40% release of platelet bound serotonin occurred. The specific effect of PAF, however, seems to be limited to induce reversible aggregation since second wave of aggregation and serotonin release were suppressed by a combination of acetylsalicylic acid and an ADP scavenging system. Incubation of PAF for 30 min in plasma resulted in a 90% loss of its platelet aggregating power. Subthreshold concentrations of PAF enhanced the platelet aggregation triggered by suboptimal concentrations of ADP, epinephrine, or collagen. Vice versa non-aggregating concentrations of ADP, epinephrine, collagen, Ca-ionophore A 23,187, or arachidonic acid amplified PAF-induced platelet aggregation. The synergistic effect of PAF and other stimuli of blood platelet activation can be partly interpreted as a stimulating effect of PAF on the metabolization of arachidonic acid.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408754     DOI: 10.1016/0049-3848(83)90235-9

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Synergistic platelet activation by aggregates of IgG and the phospholipid platelet-activating factor 1-O-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine.

Authors:  F H Valone
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

2.  Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.

Authors:  G Ostermann; B Hofmann; H P Kertscher; U Till
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

3.  Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.

Authors:  F Fouque; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

4.  Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin.

Authors:  D Lauri; C Cerletti; G de Gaetano
Journal:  Agents Actions       Date:  1986-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.